Status:
COMPLETED
Digital Therapeutic for Chronic Pain Feasibility Study
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The investigators will conduct a 2-arm randomized control feasibility study to evaluate: 1) the feasibility of using the mobile app and an optional activity tracker, 2) the feasibility of conducting a...
Detailed Description
This study will evaluate the existing 2Morrow Chronic Pain Self-Management Program, in the form of a mobile app, as a digital therapeutic for improving patients' pain self management and function who ...
Eligibility Criteria
Inclusion
- \>=18 years old
- at least one ICD pain related diagnosis noted in the electronic health record (EHR)
- at least 2 visits in a primary care clinic with at least one in the last 12 months
- willing to use a mobile app in English
- T-score for the PROMIS brief pain inventory of \>= 55
- access to a smartphone
- willing to download and use a mobile app daily
Exclusion
- current cancer related diagnosis (to exclude cancer related chronic pain)
- plans for surgery in next 3 months
- pregnant
- currently receiving hospice care
Key Trial Info
Start Date :
August 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2024
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT06000007
Start Date
August 25 2023
End Date
July 30 2024
Last Update
October 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington Primary Care
Seattle, Washington, United States, 98116